Antimicrobial Stewardship & Healthcare Epidemiology,
Год журнала:
2022,
Номер
2(1)
Опубликована: Янв. 1, 2022
Abstract
Secondary
bacterial
infections
and
coinfections
are
an
important
complication
of
coronavirus
disease
2019
(COVID-19),
leading
to
antibiotic
overuse
increased
rates
antimicrobial
resistance
(AMR)
during
the
COVID-19
pandemic.
In
this
literature
review,
we
summarize
reported
secondary
in
patients
with
COVID-19,
impact
on
patient
outcomes,
treatment
approaches
employed,
patterns
observed.
The
data
suggest
that
although
incidence
or
is
relatively
low,
they
associated
worse
outcomes
such
as
prolonged
hospitalization,
intensive
care
unit
admission,
mechanical
ventilator
use,
mortality.
Interestingly,
prescription
typically
higher
than
coinfection
rates,
reports
AMR
common.
These
findings
highlight
need
for
improved
understanding
well
options,
mitigate
inappropriate
prescribing
AMR.
Antibiotics,
Год журнала:
2021,
Номер
10(9), С. 1079 - 1079
Опубликована: Сен. 6, 2021
Mucormycosis
in
patients
who
have
COVID-19
or
are
otherwise
immunocompromised
has
become
a
global
problem,
causing
significant
morbidity
and
mortality.
Infection
is
debilitating
fatal,
leading
to
loss
of
organs
emotional
trauma.
Radiographic
manifestations
not
specific,
but
diagnosis
can
be
made
through
microscopic
examination
materials
collected
from
necrotic
lesions.
Treatment
requires
multidisciplinary
expertise,
as
the
fungus
enters
eyes
nose
may
even
reach
brain.
Use
many
antifungal
drugs
available
limited
by
considerations
resistance
toxicity,
nanoparticles
overcome
such
limitations
reducing
toxicity
increasing
bioavailability.
The
lipid
formulation
amphotericin-B
(liposomal
Am-B)
first-line
treatment
for
mucormycosis
patients,
its
high
cost
low
availability
prompted
shift
toward
surgery,
so
that
surgical
debridement
remove
all
lesions
remains
hallmark
effective
COVID-19.
This
review
highlights
pathogenesis,
clinical
manifestation,
management
Physiology International,
Год журнала:
2022,
Номер
109(1), С. 1 - 8
Опубликована: Фев. 25, 2022
The
goal
of
our
review
was
to
gather
information
on
the
most
important
community-acquired
and
hospital-acquired
co-infections
among
coronavirus
disease
2019
(COVID-19)
patients,
examine
not
only
effect
these
outcomes
but
also
identify
possible
risk
factors
that
predispose
COVID-19
patients
co-infections.
International Journal of Molecular Sciences,
Год журнала:
2022,
Номер
23(20), С. 12526 - 12526
Опубликована: Окт. 19, 2022
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
is
a
highly
transmissible
and
pathogenic
that
has
caused
‘coronavirus
disease
2019’
(COVID-19)
pandemic
in
multiple
waves,
which
threatens
human
health
public
safety.
During
this
pandemic,
some
patients
with
COVID-19
acquired
secondary
infections,
such
as
mucormycosis,
also
known
black
fungus
disease.
Mucormycosis
serious,
acute,
deadly
fungal
infection
by
Mucorales-related
species,
it
spreads
rapidly.
Hence,
prompt
diagnosis
treatment
are
necessary
to
avoid
high
mortality
morbidity
rates.
Major
risk
factors
for
include
uncontrolled
diabetes
mellitus
immunosuppression
can
facilitate
increases
mucormycosis
infections.
The
extensive
use
of
steroids
prevent
the
worsening
lead
infection.
Generally,
antifungal
agents
dedicated
medical
applications
must
be
biocompatible,
non-toxic,
easily
soluble,
efficient,
hypoallergenic.
They
should
provide
long-term
protection
against
growth.
COVID-19-related
causes
severe
increase
fatalities.
Therefore,
there
strong
need
development
novel
efficient
antimicrobial
agents.
Recently,
nanoparticle-containing
products
available
market
have
been
used
bacterial
growth,
but
little
about
their
efficacy
respect
preventing
especially
fungus.
present
review
focuses
on
effect
various
types
metal
nanoparticles,
specifically
those
containing
silver,
zinc
oxide,
gold,
copper,
titanium,
magnetic,
iron,
carbon,
growth
fungi.
We
particularly
focused
how
these
nanoparticles
impact
discussed
co-infection
context
global
outbreak,
management
guidelines
help
control
COVID-19-associated
Finally,
aimed
elucidate
relationship
between
mucormycosis.
Journal of Epidemiology and Global Health,
Год журнала:
2022,
Номер
12(2), С. 188 - 195
Опубликована: Апрель 9, 2022
Abstract
Background
Coinfection
at
various
sites
can
complicate
the
clinical
course
of
coronavirus
disease
2019
(COVID-19)
patients
leading
to
worse
prognosis
and
increased
mortality.
We
aimed
investigate
occurrence
coinfection
in
critically
ill
COVID-19
cases,
predictive
role
routinely
tested
biomarkers
on
admission
for
Methods
This
is
a
retrospective
study
all
SARS-CoV-2-infected
who
were
admitted
King
Fahad
Hospital
University
between
March
2020
December
2020.
reviewed
data
electronic
charts
healthcare
information
management
system
including
initial
presentation,
course,
radiological
laboratory
findings
reported
significant
microbiological
cultures
that
indicated
antimicrobial
therapy.
The
mortality
severely
critical
care
units.
Results
Of
1091
patients,
there
70
fatalities
(6.4%).
182
persons
service,
whom
114
(62.6%)
survived.
in-hospital
was
13.4%.
noted
67/68
non-survivors,
Gram-negative
pathogens
(
Enterobacterales
,
Pseudomonas
aeruginosa
Acinetobacter
baumanni)
represented
more
than
50%
etiological
agents.
serum
procalcitonin
higher
non-survivors
(Median
=
1.6
ng/mL
±
4.7)
survivors
0.2
4.2)
p
≤
0.05).
Conclusion
serious
complication
especially
presence
co-morbidities.
High
levels
may
predict
non-survival
cases
bacterial
or
fungal
co-infection
likely.
Antimicrobial Stewardship & Healthcare Epidemiology,
Год журнала:
2022,
Номер
2(1)
Опубликована: Янв. 1, 2022
Abstract
Secondary
bacterial
infections
and
coinfections
are
an
important
complication
of
coronavirus
disease
2019
(COVID-19),
leading
to
antibiotic
overuse
increased
rates
antimicrobial
resistance
(AMR)
during
the
COVID-19
pandemic.
In
this
literature
review,
we
summarize
reported
secondary
in
patients
with
COVID-19,
impact
on
patient
outcomes,
treatment
approaches
employed,
patterns
observed.
The
data
suggest
that
although
incidence
or
is
relatively
low,
they
associated
worse
outcomes
such
as
prolonged
hospitalization,
intensive
care
unit
admission,
mechanical
ventilator
use,
mortality.
Interestingly,
prescription
typically
higher
than
coinfection
rates,
reports
AMR
common.
These
findings
highlight
need
for
improved
understanding
well
options,
mitigate
inappropriate
prescribing
AMR.